EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TriDTI: tri-modal representation learning with cross-modal alignment for drug–target interaction prediction

Gwang-Hyeon Yun iD, Jong-Hoon Park iD, Young-Rae Cho iD

Briefings in Bioinformatics · 2026

DOI: 10.1093/bib/bbag034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2026. Verfasst von Gwang-Hyeon Yun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Software, Yonsei University Mirae Campus, 1 Yeonsedae-gil, Wonju-si, Gangwon-do, 26493, Republic of Korea. Hauptthemen laut MEDLINE: Drug Discovery, Proteins, Computational Biology. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid advancement of artificial intelligence has positioned drug–target interaction (DTI) prediction as a promising approach in drug screening and drug discovery. Recent research has attempted to use pharmacological multimodal information to increase prediction accuracy. However, existing approaches are limited in fully utilizing more than three modalities, primarily due to information loss during the modality integration process. To overcome this challenge, we propose TriDTI, a novel framework that incorporates three modalities for both drugs and proteins. Specifically, TriDTI integrates structural, sequential, and relational modalities from both entities. To mitigate information loss during integration, we employ projection and cross-modal contrastive learning for modality alignment. Furthermore, we design a fusion strategy that combines soft attention and cross-attention to effectively integrate multimodal representations. Extensive experiments on three benchmark datasets demonstrate that TriDTI consistently achieves superior performance to existing state-of-the-art approaches in DTI prediction. Moreover, TriDTI exhibits a robust generalization ability across three challenging cold-start scenarios, effectively predicting interactions involving novel drugs, targets, and bindings. These results highlight the potential of TriDTI as a robust and practical framework for facilitating drug discovery. The source codes and datasets are publicly accessible at https://github.com/knhc1234/TriDTI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryProteinsComputational BiologyRepresentation Machine LearningHumansAlgorithms

Stichwörter der Autor:innen

drug–target interaction predictionmodality alignmenttri-modal representation learning

Substanzen

Proteins

Autor:innen und Institutionen

  • Department of Software, Yonsei University Mirae Campus, 1 Yeonsedae-gil, Wonju-si, Gangwon-do, 26493, Republic of Korea.
  • Department of Digital Healthcare, Yonsei University Mirae Campus, 1 Yeonsedae-gil, Wonju-si, Gangwon-do, 26493, Republic of Korea.

ORCID-Profile: Gwang-Hyeon Yun, Jong-Hoon Park, Young-Rae Cho

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT
  • Ministry of Education
  • Regional Innovation System & Education (RISE)
  • Ministry of Education and the Gangwon State, Republic of Korea

Zitieren

APA

Yun, G. H., Park, J. H., & Cho, Y. R. (2026). TriDTI: tri-modal representation learning with cross-modal alignment for drug–target interaction prediction. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbag034

Vancouver

Yun GH, Park JH, Cho YR. TriDTI: tri-modal representation learning with cross-modal alignment for drug–target interaction prediction. Briefings in Bioinformatics. 2026. doi:10.1093/bib/bbag034

BibTeX
@article{Yun2026,
  author = {Yun, Gwang-Hyeon and Park, Jong-Hoon and Cho, Young-Rae},
  title = {TriDTI: tri-modal representation learning with cross-modal alignment for drug–target interaction prediction},
  journal = {Briefings in Bioinformatics},
  year = {2026},
  doi = {10.1093/bib/bbag034}
}
Kostenlos starten →